The World Health Organization (WHO) has announced that it may take up to nine months before a vaccine targeting the current Bundibugyo strain of Ebola becomes available.
The warning comes as health authorities continue monitoring the spread of the deadly virus and intensify efforts to contain outbreaks in affected regions.
According to WHO advisor Dr. Vasee Moorthy, two potential “candidate vaccines” are currently under development for the Bundibugyo species of Ebola. However, neither vaccine has yet undergone clinical trials, meaning scientists still need to test their safety and effectiveness before they can be approved for public use.
WHO Faces Race Against Time
The Bundibugyo strain is one of several known species of the Ebola virus. While less common than the Zaire strain, it remains highly dangerous and capable of causing severe outbreaks with significant loss of life.
Health experts warn that vaccine development is a complex process that requires careful scientific evaluation. Clinical trials are necessary to determine whether the vaccines can effectively protect people without causing harmful side effects.
“The process cannot be rushed beyond safety limits,” WHO officials emphasized, noting that global cooperation and funding will be critical in accelerating research.
Ebola Outbreak Raises Global Concern
The announcement has raised concern among international health organizations, especially in African countries vulnerable to Ebola outbreaks. Governments and medical teams are focusing on surveillance, isolation measures, contact tracing, and public awareness campaigns while waiting for vaccine solutions.
WHO continues to urge communities to follow health guidelines aimed at reducing transmission, including avoiding contact with infected individuals and reporting suspected cases quickly.
Candidate Vaccines Offer Hope
Despite the challenges, the development of two candidate vaccines represents a significant step forward in the fight against Ebola. Scientists remain optimistic that successful trials could eventually provide protection against the Bundibugyo species and help prevent future outbreaks.
The WHO has pledged continued support for vaccine research and emergency response efforts as the world watches closely for progress.
JOSHMISHUMBI
